SLC12A5 and cancer: An interesting result in the current study was that SLC12A5 expression was significantly associated with various immune infiltration levels in human cancers, especially in PRAD, LUSC, LUAD, LGG, KIRP, KIRC, HNSC, CHOL, and BRCA, suggesting that SLC12A5 may mediate cancer progression by affecting the immune infiltrate in malignancies.